These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 847240

  • 21. Evaluation of vaginal delivery systems containing 15[s]15-methyl PGF2alpha methyl ester.
    Spilman CH, Beuving DC, Forbes AD, Roseman TJ, Larion LJ.
    Prostaglandins; 1976; 12 Suppl():1-16. PubMed ID: 968060
    [Abstract] [Full Text] [Related]

  • 22. [Effect of 15-methyl-prostaglandin F2 alpha used for dilating the cervix uteri before abortion on endogenous prostaglandin F2 alpha synthesis].
    Goncharova VN, Morozova MS, Razina LG, Manuilova IA, Murashko LE.
    Akush Ginekol (Mosk); 1981 Dec; (12):37-8. PubMed ID: 6950671
    [Abstract] [Full Text] [Related]

  • 23. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ, Corson SL.
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [Abstract] [Full Text] [Related]

  • 24. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S, Brenner PF, Marrs RP, Mishell DR.
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF, Marrs RP, Roy S, Mishell DR.
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [Abstract] [Full Text] [Related]

  • 28. Serum hormone levels in women undergoing abortion with intra-amniotic, extra-amniotic or intra-muscular administration of 15(S) 15-methyl-prostaglandin F2alpha.
    Puri CP, Rahman SA, Jain AK, Bhaduri R, Singh CM, Hingorani V, Laumas KR.
    Prostaglandins; 1976 May; 11(5):905-23. PubMed ID: 935519
    [Abstract] [Full Text] [Related]

  • 29. The current status of prostaglandins as abortifacients.
    Brenner WE.
    Am J Obstet Gynecol; 1975 Oct 01; 123(3):306-28. PubMed ID: 810025
    [Abstract] [Full Text] [Related]

  • 30. Abortifacient effect and uterine cervix-dilating action of 16, 16-dimethyl trans delta 2 PGE1 methyl ester (ONO 802) in the form of a vaginal suppository (a randomized, double-blind, controlled study in the second trimester of pregnancy).
    Sakamoto S, Satoh K, Nishiya I, Kunimoto K, Chimura T, Oda T, Takeuchi S, Satoh Y, Iizuka R, Kobayashi T, Takagi S, Yoshida T, Tomoda Y, Ninagawa T, Kurachi K, Tanizawa O, Tojo S, Mochizuki M, Maeda K, Tominaga Y, Torigoe T, Koresawa M, Taki I, Hamada T.
    Prostaglandins Leukot Med; 1982 Sep 01; 9(3):349-61. PubMed ID: 6752961
    [Abstract] [Full Text] [Related]

  • 31. Early pregnancy-abortion model using sulprostone.
    Fleischer A, Schulman H, Blattner P, Jagani N, Fayemi A.
    Prostaglandins; 1982 May 01; 23(5):643-55. PubMed ID: 7122906
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Outpatient postconceptional fertility control with vaginally administered 15(S) 15-methyl-PGF2alpha-methyl ester.
    Bygdeman M, Martin JN, Eneroth P, Leader A, Lundström V.
    Am J Obstet Gynecol; 1976 Mar 01; 124(5):495-8. PubMed ID: 1258906
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Low-dose vaginal 15 methyl prostaglandin F2 alpha for cervical dilatation prior to vacuum curettage abortion.
    Niloff JM, Stubblefield PG.
    Am J Obstet Gynecol; 1982 Mar 01; 142(5):596-7. PubMed ID: 7036748
    [Abstract] [Full Text] [Related]

  • 37. Suppression of concentration of endometrial prostaglandin in early intra-uterine and ectopic pregnancy in women.
    Abel MH, Smith SK, Baird DT.
    J Endocrinol; 1980 Jun 01; 85(3):379-86. PubMed ID: 7411005
    [Abstract] [Full Text] [Related]

  • 38. Vaginally administered PGF2alpha for cervical dilatation in nulliparas prior to suction curettage.
    Brenner WE, Dingfelder JR, Staurovsky LG, Hendricks CH.
    Prostaglandins; 1973 Dec 01; 4(6):819-36. PubMed ID: 4783581
    [Abstract] [Full Text] [Related]

  • 39. Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
    Int J Gynaecol Obstet; 1983 Apr 01; 21(2):159-65. PubMed ID: 6136437
    [Abstract] [Full Text] [Related]

  • 40. Luteolytic and abortifacient effects of serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha in early pregnancy.
    Lauersen NH, Wilson KH.
    Am J Obstet Gynecol; 1976 Feb 15; 124(4):425-9. PubMed ID: 1251863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.